Revvity, Inc.

Revvity is a leading provider of health science solutions, technologies, expertise, and services. The company delivers complete workflows from discovery to development, and diagnosis to cure. Revvity focuses on specialized areas including translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. Headquartered in Waltham, Massachusetts, Revvity markets its products and services in more than 160 countries. As of December 28, 2025, the company employed approximately 11,000 employees. Revvity's common stock is listed on the New York Stock Exchange under the symbol "RVTY" and is a component of the S&P 500 Index. The company's strategy involves developing and delivering innovative products, services, and solutions in high-growth markets, utilizing its knowledge and expertise to address customer needs and drive scientific breakthroughs. To accelerate revenue growth, Revvity broadens its offerings through investment in research and development and the acquisition of innovative technology.